IFP Advisors’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
IFP Advisors's OBIO Position: Q3 2026 in Review
IFP Advisors increased its Orchestra BioMed (OBIO) stake by 1% in Q3 2026, buying an estimated $4.41K and bringing the position to 90,528 shares worth $563K. The position accounts for 0.01% of the portfolio, ranked #1001.
IFP Advisors first reported a position in OBIO in Q1 2023 and has held it in 15 quarters since. The position peaked at $693K in Q1 2025. 93 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- IFP Advisors held 90,528 shares of Orchestra BioMed worth $563K as of Q3 2026.
- IFP Advisors bought 920 Orchestra BioMed shares in Q3 2026, an estimated $4.41K.
- Orchestra BioMed made up 0.01% of IFP Advisors's portfolio in Q3 2026, its #1001 holding.
- IFP Advisors first reported a position in Orchestra BioMed in Q1 2023 and has held it in 15 quarters since.
- IFP Advisors's Orchestra BioMed position peaked at $693K in Q1 2025.
- 93 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.